Related Experiment Video
Updated: May 8, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
Evaluating and monitoring treatment response in depression using measurement-based assessment and rating scales
1Department of Psychiatry and Mood Disorders Research Program and Clinic, University of Texas Southwestern Medical Center, Dallas, USA.
Abstract:
Even with many treatment options available for major depressive disorder, many patients fail to achieve remission and return to their presymptomatic levels of functioning at work, in leisure activities, and in relationships. Throughout treatment, clinicians should implement measurement-based care by systematically monitoring patients' response using self-rated scales, such as the PHQ-9, QIDS-SR, or BDI. By tracking depressive symptoms, as well as suicidality, treatment adherence, and side effects, clinicians can adjust treatment to help patients achieve the best outcomes. Measurement-based care enables clinicians to make informed decisions at critical points throughout the treatment process and to involve patients in making those decisions.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Depression: Overview
Measurement of Bioavailability: Pharmacodynamic Methods
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring: Affecting Factors
Cognitive Therapy

